Literature DB >> 32025963

Skin burn related to pulse oximetry during photodynamic therapy using talaporfin sodium.

Yuka Ino1, Midori Nakashima2, Tomonori Morita3, Yoko Hori2, Hiroaki Kishikawa2, Nobutoshi Hagiwara4, Takeshi Matsutani4, Tsutomu Nomura4, Atsuhiro Sakamoto2.   

Abstract

Entities:  

Keywords:  Photodynamic therapy; Pulse oximetry; Skin burn; Skin phototoxicity; Talaporfin sodium

Year:  2018        PMID: 32025963      PMCID: PMC6967261          DOI: 10.1186/s40981-018-0203-0

Source DB:  PubMed          Journal:  JA Clin Rep        ISSN: 2363-9024


× No keyword cloud information.

To the editor

Photodynamic therapy (PDT) is a less invasive cancer treatment [1]. One of the complications of PDT is phototoxicity because of the photosensitizer [2]. Recent clinical studies showed that no skin phototoxicity was observed during or after PDT using talaporfin sodium for esophageal cancer [3, 4]. A 58-year-old woman with esophageal cancer underwent esophagostomy and chemoradiation. However, the cancer grew extensively. PDT was scheduled. Talaporfin sodium was intravenously administered before PDT. We planned general anesthesia. Standard monitoring included pulse oximetry (Radical-7, Masimo Corp., Irvine, CA). We attached the pulse oximeter probes (M-LNCS Neo, Masimo Corp., Irvine, CA) to specific digits. We measured peripheral oxygen saturation for 10 min each, alternating between left and right hand. We decided to change the fingers in 10 min just from experience. The patient underwent laser beam irradiation. Semiconductor laser light of 664 nm was used. The next day, the patient showed blistering on both digits, on which the pulse oximeter probes had been applied (Fig. 1). The skin burns were treated conservatively and healed spontaneously for 2 weeks without pigmentation.
Fig. 1

Blister on the left ring finger where the pulse oximeter had been placed during general anesthesia

Blister on the left ring finger where the pulse oximeter had been placed during general anesthesia Whether PDT is performed under general anesthesia or sedation depends on each surgeon’s decision. In our institution, PDT under general anesthesia was selected for the stable operation field. The technique of pulse oximetry is based on the principle that oxygenated hemoglobin and deoxygenated hemoglobin absorb red and near-infrared light differently [5]. The MASIMO pulse oximeter probe emits red light at 660 nm and infrared light at 940 nm. Moreover, talaporfin sodium has a longer absorption at 664 nm, and the laser light of 664 nm activates talaporfin sodium as an anticancer drug [3, 4]. Both the red light emitted by pulse oximetry and the laser light are characterized by the same wavelength zone, leading us to conclude that the blister was photosensitivity dermatitis caused by the red light from the pulse oximeter. All pulse oximeter probes use similar wavelengths. Pulse oximeter sensory associated blisters must occur when using other probes. There were two previous reports of skin burns related to pulse oximetry using photofrin and mTHPC during PDT. Probes were continuously applied to patients’ fingers for 3 and 48 h [6, 7]. We predicted that shorter exposure time to red light from pulse oximetry would prevent skin phototoxicity. Nevertheless, this case showed that pulse oximetry can cause skin burns regardless of the length of pulse oximetry attachment time and the kinds of photosensitizers. Pulse oximetry is a standard monitor in anesthesia cases to detect hypoxia [5]. The World Health Organization recommends pulse oximetry for all anesthetic patients for perioperative safety [8]. There is no superior monitoring to pulse oximetry for measuring oxygenation, even during PDT. Therefore, we should monitor peripheral oxygen saturation by pulse oximetry as little as possible or intermittently. In future cases, we might need arterial cannulation to assess blood oxygenation, if we will not be able to apply pulse oximetry. Before PDT, the anesthesiologist should inform the patient regarding the possibility of skin burns related to pulse oximetry.
  6 in total

1.  Pulse oximeter as a cause of skin burn during photodynamic therapy.

Authors:  A Radu; M Zellweger; P Grosjean; P Monnier
Journal:  Endoscopy       Date:  1999-11       Impact factor: 10.093

2.  Skin burn associated with pulse oximetry during perioperative photodynamic therapy.

Authors:  N E Farber; J McNeely; D Rosner
Journal:  Anesthesiology       Date:  1996-04       Impact factor: 7.892

Review 3.  Photodynamic therapy for esophageal cancer.

Authors:  Tomonori Yano; Ken Hatogai; Hiroyuki Morimoto; Yusuke Yoda; Kazuhiro Kaneko
Journal:  Ann Transl Med       Date:  2014-03

Review 4.  Photodynamic therapy for cancer.

Authors:  Dennis E J G J Dolmans; Dai Fukumura; Rakesh K Jain
Journal:  Nat Rev Cancer       Date:  2003-05       Impact factor: 60.716

5.  Phase I study of photodynamic therapy using talaporfin sodium and diode laser for local failure after chemoradiotherapy for esophageal cancer.

Authors:  Tomonori Yano; Manabu Muto; Kenichi Yoshimura; Miyuki Niimi; Yasumasa Ezoe; Yusuke Yoda; Yoshinobu Yamamoto; Hogara Nishisaki; Koji Higashino; Hiroyasu Iishi
Journal:  Radiat Oncol       Date:  2012-07-23       Impact factor: 3.481

6.  A multicenter phase II study of salvage photodynamic therapy using talaporfin sodium (ME2906) and a diode laser (PNL6405EPG) for local failure after chemoradiotherapy or radiotherapy for esophageal cancer.

Authors:  Tomonori Yano; Hiroi Kasai; Takahiro Horimatsu; Kenichi Yoshimura; Satoshi Teramukai; Satoshi Morita; Harue Tada; Yoshinobu Yamamoto; Hiromi Kataoka; Naomi Kakushima; Ryu Ishihara; Hajime Isomoto; Manabu Muto
Journal:  Oncotarget       Date:  2017-03-28
  6 in total
  2 in total

1.  Outdoor-Useable, Wireless/Battery-Free Patch-Type Tissue Oximeter with Radiative Cooling.

Authors:  Min Hyung Kang; Gil Ju Lee; Joong Hoon Lee; Min Seok Kim; Zheng Yan; Jae-Woong Jeong; Kyung-In Jang; Young Min Song
Journal:  Adv Sci (Weinh)       Date:  2021-03-09       Impact factor: 16.806

2.  An in vitro study of the effect of 5-ALA-mediated photodynamic therapy on oral squamous cell carcinoma.

Authors:  Ying Ma; Shujuan Qu; Liangpeng Xu; Hongbo Lu; Baoguo Li
Journal:  BMC Oral Health       Date:  2020-09-16       Impact factor: 2.757

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.